European Journal of Cardiovascular Medicine

Objectives: Coronavirus disease2019 (COVID-19) has created an extraordinary health crisis worldwide.Given the infancy of the pandemic and limited data available for managing it in susceptible populations like pregnant women and neonates, there arises a need to understand the implications of this disease to formulate appropriate guidelines. Hence, this study assessed the clinical features, maternal and neonatal outcomes of COVID-19. Methods: This retrospective cross-sectional research study collected data from101COVID-19positive pregnant women using their case records. Variables analyzed included gestational age, symptoms, maternal investigations, period between test positivity and delivery, mode of delivery, maternal ICU admission/need for respiratory support, maternal mortality rate, and neonatal outcome. Results: Mean gestational age for becoming COVID positive was 36.03 ± 6.66 weeks (3rd trimester). Most cases (69%) were asymptomatic, while some had fever (15.84%), cough (12.87%), and elevated serum ferritin levels (32.67%). Obstetric complications were observed in 61.39% of the cases and 70.3% had cesarean deliveries, most likely due to oligohydramnios (15.49%). No case required ICU admission, but some required heparin (87.13%), steroids (9.9%), remdesivir medication (4.95%), and respiratory support (3.96%). Owing to 2 twin pregnancies, 83 mothers gave birth to 85 babies with a mean neonatal birthweightof2.97 ± 0.47 Kg. No babies were COVID positive and only 4.71% were admitted to NICU. Conclusion: No worsening of maternal and neonatal outcomes due to COVID 19 infection were seen.  Obstetrical complications like gestational diabetes mellitus (GDM)&pregnancy induced hypertension (PIH)were existing conditions in pregnant women.